Influence of the anti-CD25 monoclonal antibody BT563 on clinical and biological rejection after orthotopic liver transplantation.
Otto
G
G
Department of General Surgery, University of Heidelberg, Germany.
Hofmann
W J
WJ
Gaweco
A S
AS
Seelos
R
R
Herfarth
C
C
Meuer
S
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000096:biosynthesis; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology; D008775:Methylprednisolone / Q000627:therapeutic use; D010865:Pilot Projects; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis / Q000276:immunology*; D014158:Transcription, Genetic
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; C079843:inolimomab; D001379:Azathioprine; D008775:Methylprednisolone